CUSIP: 03835L207
What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 03835L207:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 0 | $0 | -$349,708 | 0 | |
| 2023 Q4 | 1,933,445 | $349,708 | -$275,184 | $0.18 | 29 |
| 2023 Q3 | 3,409,316 | $1,125,754 | +$789,583 | $0.33 | 26 |
| 2023 Q2 | 928,804 | $1,359,729 | +$34,650 | $1.46 | 23 |
| 2023 Q1 | 891,596 | $1,815,910 | -$162,921 | $2.04 | 24 |
| 2022 Q4 | 963,250 | $2,271,536 | +$237,695 | $2.32 | 26 |
| 2022 Q3 | 867,109 | $2,635,000 | +$169,943 | $3.04 | 20 |
| 2022 Q2 | 794,528 | $2,845,000 | -$106,985 | $3.58 | 18 |
| 2022 Q1 | 811,717 | $4,763,000 | +$288,471 | $5.87 | 18 |
| 2021 Q4 | 760,574 | $5,985,000 | -$32,769,680 | $7.87 | 17 |
| 2021 Q3 | 2,724,924 | $42,069,000 | -$5,676,158 | $15.44 | 21 |
| 2021 Q2 | 2,921,818 | $65,535,000 | -$2,127,443 | $22.43 | 25 |
| 2021 Q1 | 2,943,834 | $89,749,000 | +$726,907 | $30.52 | 32 |
| 2020 Q4 | 2,913,378 | $106,761,000 | +$86,547,216 | $36.65 | 34 |
| 2020 Q3 | 659,105 | $5,002,000 | +$50,866 | $7.58 | 16 |
| 2020 Q2 | 632,159 | $5,276,105 | +$1,169,224 | $8.35 | 18 |
| 2020 Q1 | 483,678 | $1,789,466 | +$1,789,466 | $3.70 | 12 |